To investigate whether laboratory tests at admission differentiate PIMS-TS from acute COVID-19 patients, partial least-squares discriminant analysis (PLS-DA) was performed, including the following parameters: haemoglobin, platelets, white blood cells, neutrophils, lymphocyte counts, CRP, sodium, urea, and creatinine (Figure 2). The gene discussed is CRP; the disease is COVID-19.